Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes

Fulcher, G; Matthews, DR; Perkovic, V; de Zeeuw, D; Mahaffey, KW; Mathieu, C; Woo, V; Wysham, C; Capuano, G; Desai, M; Shaw, W; Vercruysse, F; Meininger, G; Neal, B; Home, P; Anderson, J; Campbell, I; Lachin, J; Scharfstein, D; Solomon, S; Uzzo, R; Amerena, J; Chow, C; Figtree, G; French, G; Hillis, J; Jenkins, B; Lindley, R; McGrath, B; Street, A; Watson, J

Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes

journal contribution

posted on 2024-06-13, 14:45 authored by G Fulcher, DR Matthews, V Perkovic, D de Zeeuw, KW Mahaffey, C Mathieu, V Woo, C Wysham, G Capuano, M Desai, W Shaw, F Vercruysse, G Meininger, B Neal, P Home, J Anderson, I Campbell, J Lachin, D Scharfstein, S Solomon, R Uzzo, J Amerena, C Chow, G Figtree, G French, J Hillis, B Jenkins, R Lindley, B McGrath, A Street, J Watson

Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes

History

Journal

Diabetes, Obesity and Metabolism

Volume

18

Pagination

82-91

Location

Chichester, Eng.

ISSN

1462-8902

eISSN

1463-1326

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Issue

1

Publisher

Wiley

Usage metrics

Keywords

3202 Clinical sciences

Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes

History

Journal

Volume

Pagination

Location

ISSN

eISSN

Language

Publication classification

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports